In an interview, sleep medicine experts Milena K Pavlova, MD, and Rachel Ziegler, MD, discuss the latest developments in sleep disorder therapies and the existing gaps in sleep medicine.
Researchers assessed whether zolpidem (priming) is required for partial reinforcement or whether intermittent dosing with placebos can be effective for acute and extended treatment for patients with chronic insomnia.
Researchers assessed the sex-specific association between self-reported sleep duration and mortality in an East Asian population.
A team of researchers plans to test the feasibility and acceptability of cognitive behavioral therapy for veterans with insomnia and alcohol use disorder.
Researchers studied the impact of obesity and metabolic syndrome on sleep-disordered breathing and/or sleep duration in a group of Hispanic and Latino adults who had experienced cognitive decline.
The American Academy of Sleep Medicine provided a position statement on the importance of sleep in health and several objectives to improve health, productivity, and well-being.
Sleep disturbances may affect 40% to 90% of patients with PD, and a 2020 study found that about half of patients with PD had multiple sleep disorders.
While sleep dysregulation is a feature of dementia, it remains unclear whether the duration of sleep prior to old age is associated with dementia. The researchers examined the association between sleep duration and incidence of dementia using a 25-year follow-up.
To learn more about the potential role of cannabinoids in the management of sleep disorders, we interviewed Aleksandra M. Kwasnik, MD, who recently coauthored a review on the topic.
Although sleep disorders are often difficult to treat, increased knowledge regarding the disordered sleep associated with ASD could lead to effective treatments for these patients.
